Most Read Articles
13 Apr 2020
The inherent limitations of using tumour tissues for genomic profiling has led to the need for a more efficient, easily accessible yet accurate method of evaluating biomarkers to facilitate personalised medicine. At the ESMO Asia Colloquia chaired by Professor Byoung Chul Cho of Yonsei Cancer Centre, experts in the field of precision oncology shared insights on the diagnostic, prognostic and predictive values of tumour-derived blood biomarkers (liquid biopsy) for the management of various cancer types.

State-of-the-Art Diagnostics and Therapeutics in Cancer

14 Nov 2019
Cancer is a global epidemic of the modern world, and millions are diagnosed with it each year. Thankfully, constant advancements in medicine and medical technology are slowly but surely tipping the battle against cancer in our favour. In a symposium held in Singapore by Parkway Cancer Centre and Gleneagles Hospital, a team of medical oncologists, surgeons and a molecular pathologist shared some of the latest developments in cancer diagnostics and therapeutics.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Singapore digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
13 Apr 2020
The inherent limitations of using tumour tissues for genomic profiling has led to the need for a more efficient, easily accessible yet accurate method of evaluating biomarkers to facilitate personalised medicine. At the ESMO Asia Colloquia chaired by Professor Byoung Chul Cho of Yonsei Cancer Centre, experts in the field of precision oncology shared insights on the diagnostic, prognostic and predictive values of tumour-derived blood biomarkers (liquid biopsy) for the management of various cancer types.